CIPO Patents = 1

Trademarks = 5

Forward Citations = 8

Loading Chart...

2 inventors (with patents filed for the assignee):

Simon Beaudoin (8 out of 9 patents)

Jeffrey Victor Leyton (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 12350346 - Conjugates enhancing total cellular accumulation (2025-07-08),

2. 12233130 - Covalently-modified steroid acid-peptides having enhanced stability and/or biological activity (2025-02-25),

3. 12150989 - Covalently modified antigens for improved immune response and/or stability (2024-11-26),

4. 12076396 - Steroid acid-based immunogen enhancers (2024-09-03),

5. 11890350 - Steroid acid-peptide based cytotoxic compounds (2024-02-06),

6. 11612651 - Steroid acid-based immunogen enhancers (2023-03-28),

7. 11352437 - Conjugates enhancing total cellular accumulation (2022-06-07),

8. 11291717 - Covalently modified antigens for improved immune response and/or stability (2022-04-05),

Defence Therapeutics Inc. is a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases. Their proprietary technology platform allows for the rapid design and development of innovative drug candidates with enhanced efficacy and safety profiles. With a strong pipeline of potential therapies, Defence Therapeutics is poised to make a significant impact in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

8 Patents

#111 in Vancouver

#1,808 in Canada

Vancouver, Canada

Defence Therapeutics Inc.

Forward Citations = 8

2 inventors:

Simon Beaudoin (8 out of 9 patents)

Jeffrey Victor Leyton (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com